Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Total Current Liabilities (2016 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Total Current Liabilities for 14 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities fell 19.89% year-over-year to $1.3 million, compared with a TTM value of $1.3 million through Dec 2025, down 19.89%, and an annual FY2025 reading of $2.3 million, up 4.06% over the prior year.
  • Total Current Liabilities was $1.3 million for Q4 2025 at Neuroone Medical Technologies, down from $2.3 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $3.1 million in Q3 2022 and bottomed at $746852.0 in Q2 2021.
  • Average Total Current Liabilities over 5 years is $1.5 million, with a median of $1.5 million recorded in 2024.
  • The sharpest move saw Total Current Liabilities crashed 82.82% in 2021, then surged 162.22% in 2022.
  • Year by year, Total Current Liabilities stood at $1.1 million in 2021, then increased by 25.64% to $1.3 million in 2022, then rose by 3.63% to $1.4 million in 2023, then increased by 13.57% to $1.6 million in 2024, then decreased by 19.89% to $1.3 million in 2025.
  • Business Quant data shows Total Current Liabilities for NMTC at $1.3 million in Q4 2025, $2.3 million in Q3 2025, and $1.4 million in Q2 2025.